 |
|
UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
June 08, 2007Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today's most promising anticancer drugs and thereby increase their effectiveness.
The poor solubility of anticancer drugs is one of the major problems in cancer therapy because the drugs require the addition of solvents in order to be easily absorbed into cancer cells. Unfortunately, these solvents not only dilute the potency of the drugs but create toxicity as well.
In a paper scheduled to be published in the nanoscience journal Small in June, researchers from UCLA's California NanoSystems Institute and Jonsson Cancer Center report a novel approach using silica-based nanoparticles to deliver the anticancer drug camptothecin and other water-insoluble drugs into human cancer cells.
The study is led by Fuyu Tamanoi, UCLA professor of microbiology, immunology and molecular genetics and director of the Jonsson Cancer Center's Signal Transduction and Therapeutics Program Area, and Jeffrey Zink, UCLA professor of chemistry and biochemistry.
Tamanoi and Zink devised a method for incorporating the representative hydrophobic anticancer drug camptothecin into the pores of fluorescent mesoporous silica nanoparticles and delivering the particles into a variety of human cancer cells to induce cell death. The results suggest that the mesoporous silica nanoparticles might be used as a vehicle to overcome the insolubility problem of many anticancer drugs.
"Silica nanomaterials show promise for delivering camptothecin and other water-insoluble drugs," Tamanoi said. "We have successfully loaded hydrophobic anticancer drugs into mesoporous nanoparticles and delivered them into human cancer cells to induce cell death."
"The beauty of our findings is that these nanoparticles are biocompatible, contain tubular pores and are relatively easy to modify," Zink said. "Additional modification by attaching a ligand against a cancer-cell-specific receptor can make the nanoparticles recognizable by cancer cells."
A critical obstacle and challenge for cancer therapy is the limited availability of effective biocompatible delivery systems. Since many effective anticancer agents have poor water solubility, the development of novel delivery systems for these molecules without the use of organic solvents has received significant attention.
Camptothecin (CPT) and its derivatives are considered to be among the most effective anticancer drugs of the 21st century. Although studies have demonstrated their effectiveness against carcinomas of the stomach, colon, neck and bladder, as well as against breast cancer, small-cell lung cancer and leukemia in vitro, clinical application of CPT in humans has only been carried out with CPT derivatives that have improved water solubility.
"In order to be used on humans, current cancer therapies such as CPT or Taxol, which are poorly water soluble, must be mixed with organic solvents in order to be delivered into the body," Tamanoi said. "These elements produce toxic side effects and in fact decrease the potency of the cancer therapy."
To overcome these problems, drug delivery systems using pegylated polymers, liposomal particles or albumin-based nanoparticles have been developed.
The new research findings show that mesoporous silica nanoparticles offer great potential and a promising approach to the delivery of therapeutic agents into targeted organs or cells. The pores in the nanoparticles could be closed by constructing an appropriate cap structure. This provides the ability to control the release of anticancer drugs by external stimuli.
University of California - Los Angeles
The study is led by Fuyu Tamanoi, UCLA professor of microbiology, immunology and molecular genetics and director of the Jonsson Cancer Center's Signal Transduction and Therapeutics Program Area, and Jeffrey Zink, UCLA professor of chemistry and biochemistry.
Tamanoi and Zink devised a method for incorporating the representative hydrophobic anticancer drug camptothecin into the pores of fluorescent mesoporous silica nanoparticles and delivering the particles into a variety of human cancer cells to induce cell death. The results suggest that the mesoporous silica nanoparticles might be used as a vehicle to overcome the insolubility problem of many anticancer drugs.
"Silica nanomaterials show promise for delivering camptothecin and other water-insoluble drugs," Tamanoi said. "We have successfully loaded hydrophobic anticancer drugs into mesoporous nanoparticles and delivered them into human cancer cells to induce cell death."
"The beauty of our findings is that these nanoparticles are biocompatible, contain tubular pores and are relatively easy to modify," Zink said. "Additional modification by attaching a ligand against a cancer-cell-specific receptor can make the nanoparticles recognizable by cancer cells."
A critical obstacle and challenge for cancer therapy is the limited availability of effective biocompatible delivery systems. Since many effective anticancer agents have poor water solubility, the development of novel delivery systems for these molecules without the use of organic solvents has received significant attention.
Camptothecin (CPT) and its derivatives are considered to be among the most effective anticancer drugs of the 21st century. Although studies have demonstrated their effectiveness against carcinomas of the stomach, colon, neck and bladder, as well as against breast cancer, small-cell lung cancer and leukemia in vitro, clinical application of CPT in humans has only been carried out with CPT derivatives that have improved water solubility.
"In order to be used on humans, current cancer therapies such as CPT or Taxol, which are poorly water soluble, must be mixed with organic solvents in order to be delivered into the body," Tamanoi said. "These elements produce toxic side effects and in fact decrease the potency of the cancer therapy."
To overcome these problems, drug delivery systems using pegylated polymers, liposomal particles or albumin-based nanoparticles have been developed.
The new research findings show that mesoporous silica nanoparticles offer great potential and a promising approach to the delivery of therapeutic agents into targeted organs or cells. The pores in the nanoparticles could be closed by constructing an appropriate cap structure. This provides the ability to control the release of anticancer drugs by external stimuli.
University of California - Los Angeles
Anticancer Current Events and Anticancer News RSSUCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin.
Inhibitor of heat shock protein is a potential anticancer drug, Penn study finds
Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals - all can wreak havoc on the delicate internal components of a cell, potentially damaging it beyond repair.
URI research couple's method targets cancerous tumors
Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects.
Promising novel treatment for human cancer -- Chrysanthemum indicum extract
A series of studies have demonstrated that Chrysanthemum indicum possesses antimicrobial, antiinflammatory, immunomodulatory, and neuroprotective effects.
New cancer drug test promises safer and more effective clinical trials
A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development.
Researchers examine mechanisms that help cancer cells proliferate
A process that limits the number of times a cell divides works much differently than had been thought, opening the door to potential new anticancer therapies, researchers at UT Southwestern Medical Center report in the Aug. 7 issue of the journal Cell.
Palliative care intervention for patients with advanced cancer provides quality of life benefits
Patients with advanced cancer who received a palliative care intervention focused on addressing physical and psychosocial issues and care coordination that was provided at the same time as cancer treatment reported improved quality of life and mood but did not experience a significant change in the number of days in the hospital or the severity of their symptoms compared to patients who received usual care.
Pitt researchers harness carbon nanomaterials for drug delivery systems, oxygen sensors
Two nanoscale devices recently reported by University of Pittsburgh researchers in two separate journals harness the potential of carbon nanomaterials to enhance technologies for drug or imaging agent delivery and energy storage systems, in one case, and, in the other, bolster the sensitivity of oxygen sensors essential in confined settings, from mines to spacecrafts.
A potent and selective anti-tumor agent on human gastric cancer
A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question.
Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior.
More Anticancer Current Events and Anticancer News Articles
 |
Anticancer: A New Way of Life by David Servan-Schreiber (Author) The New York Times bestseller takes us on an empowering journey and changes the way we think about fighting cancer David Servan-Schreiber's story of his journey from cancer patient to health combines memoir with a clear scientific explanation of what makes cancer cells thrive and what inhibits them. Anticancer is filled with easy to understand charts and diagrams and a sixteen-page color "Anticancer Action" insert that enables readers to make small but essential changes in lifestyle and diet. Your body knows how to fight cancer, says Servan-Schreiber, and you have to help it with nutrition, physical exercise, stress management, and avoiding environmental toxins. Anticancer enables people living with cancer to adopt a proactive attitude to living, even thriving, with cancer and... |
 |
Anticancer, A New Way of Life, New Edition by MD, PhD, David Servan-Schreiber (Author) The New York Times and international bestseller-now updated with the latest research Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition of Anticancer includes: • The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market • New information about how vitamin D strengthens the immune system • Warnings about common food contaminants that have recently been proven to contribute to cancer progression • A new chapter on mind-body approaches to... |
 |
The Anti-Cancer Cookbook by Dr. Julia Greer (Author) Eat broccoli sprouts to prevent bladder cancer . . . Eat more blueberries to reduce your risk of colon cancer . . . It seems that every day we hear new discoveries about various foods' anti-cancer properties. But the information comes in little bits, from all different directions, and it's hard to know how to put all this information to use in your own diet to reduce your risk of getting cancer. Now, Dr. Julia Greer a physician, cancer researcher, and food enthusiast pulls together everything you need to know about anti-cancer foods into one handy book: The Anti-Cancer Cookbook. She explains what cancer is and how antioxidants work to prevent pre-cancerous mutations in your body's cells, and then describes in detail which foods have been scientifically shown to help prevent... |
 |
ANTICANCER, EL by SERVAN-SCHREIBER DAVID (Author) Esta obra es fruto de la experiencia que David Servan-Schreiber vivio hace quince anos cuando le diagnosticaron un tumor cerebral. Despues de someterse a los tratamientos medicos convencionales tuvo una recaida y decidio estudiar a fondo toda la informacion disponible relacionada con el cancer. A partir de ahi diseno una nueva forma de vida basada en la potenciacion de las capacidades del cuerpo y de la mente y beneficiosa tanto para prevenir la aparicion de esta enfermedad como para impedir su avance sin prescindir de la medicina tradicional. Su propuesta es que todos deberiamos crear una biologia anticancer mediante una alimentacion adecuada ejercicio fisico y bienestar psicologico que refuerce las defensas naturales y nos permita afrontar esta enfermedad con exito. |
 |
An Anti-Cancer Diet: Prevent & reverse cancer. Live longer & look younger. Lower cholesterol & lose weight. by Robert Korczynski (Author) Consistent with the plant-based diet recommended by the American Cancer Society, this book summarizes, in plain English, the latest findings from scientific studies related to genetic triggers, and other complex factors now known to influence health. Delicious and healthy food can be a part of your lifestyle today, if you know how to choose what's good for you. |
 |
Anticancer: A New Way of Life by David Servan-Schreiber (Author) Fifteen years ago, a frightening series of tests revealed that Dr. David Servan-Schreiber had a lethal cancer of the brain. He received conventional treatment and the cancer went into remission, but he then suffered a relapse. Dr. Servan-Schreiber, however, was in a unique position to fight back. As a physician, researcher and former director of the Center of Integrative Medicine at the University of Pittsburgh, he had access to both the latest cancer research and to a wealth of information on new approaches to treatment and prevention. Anticancer is the culmination of his research on and personal experience with cancer, both as a doctor and as a patient. It's the book he would have read to avoid getting cancer in the first place and the one he would have wanted by his side when he was... |
 |
Foods to Fight Cancer: Essential foods to help prevent cancer by Richard Beliveau (Author) Detailing the key foods that have been medically shown to be beneficial in both preventing and fighting cancer, this is the must-have resource for anyone looking to get healthy and stay that way. AUTHOR BIO: Richard Béliveau, PhD, a leading authority in cancer research, holds the Chair in the Prevention and Treatment of Cancer at the Université du Quebec à Montréal, where he is a professor of biochemistry. Denis Gingras, PhD, in an oncology researcher at the Centre de cancérologie Charles-Bruneau. |
 |
The Instinct to Heal: Curing Depression, Anxiety and Stress Without Drugs and Without Talk Therapy by Dr. David Servan-Schreiber M.D. Ph.D. (Author) Millions of Americans try drugs or talk therapy to relieve depression and anxiety, but recent scientific studies prove certain alternative treatments can work as well or better-often bringing on a cure. In this extraordinary international bestseller, award-winning psychiatrist and neuroscientist David Servan-Schreiber, M.D., Ph.D., presents seven natural approaches, each with proven results, that together form a treatment plan that builds on the body's relationship to the brain, yielding faster, more dramatic, and permanent changes. People who want to leave suffering behind now can live joyful, happy lives. |
 |
Dr. Moerman's Anti-Cancer by Ruth Jochems (Author) |
 |
Medicinal Chemistry of Anticancer Drugs by Carmen Avendano (Author), J. Carlos Menendez (Author) Antitumour chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells. These therapies are in their infancy, but they hold promise of more effective therapies with fewer side effects. Resistance to antitumour drugs is another important but normally neglected field. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumour drugs... |
| © 2009 BrightSurf.com |